AVADEL PHARMACEUTICALS PLC
Pharmaceutical Preparations · 16640 CHESTERFIELD GROVE ROAD, SUITE 200, CHESTERFIELD, MO 63005
官方登記資料
0位追蹤者
1990成立於
關於 AVADEL PHARMACEUTICALS PLC
Avadel Pharmaceuticals plc was an Irish specialty pharmaceutical company focused on sleep disorder medicines marketed for hospital and primary care treatments. Headquartered in Dublin, Ireland, it had operations in St. Louis, Missouri and Lyon, France. It was a developer of the US FDA-approved anti-narcolepsy medication LUMRYZ. It was acquired by Alkermes in February 2026.
Source: Wikipedia
產業Pharmaceutical Preparations
總部16640 CHESTERFIELD GROVE ROAD, SUITE 200, CHESTERFIELD, MO 63005
成立時間1990
狀態營運中
關鍵數據
法律資訊
| 法定名稱 | AVADEL PHARMACEUTICALS PLC |
|---|---|
| SEC CIK | 1012477在 SEC EDGAR 上查看 ↗ |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 16640 CHESTERFIELD GROVE ROAD, SUITE 200, CHESTERFIELD, MO 63005 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
16640 CHESTERFIELD GROVE ROAD, SUITE 200, CHESTERFIELD, MO 63005
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面